A Paradox and Alan Rein: Distinguished Retrovirologist Retires from the HIV DRP

From April 4–10, the Scientific Library invites you to celebrate National Library Week. This year’s theme is “Welcome to Your Library.” The Scientific Library staff is eager to greet you when in-person operations resume, but in the interim, they welcome you to explore the many services that continue beyond the four walls of the Library’s locations in Building 549 and at the Advanced Technology Research Facility.

The National Cancer Institute is currently supporting more than 6,700 clinical trials. That staggering statistic is dwarfed by the number of participants in those trials, many of whom are cancer patients. Even more astounding is that these numbers are for just this moment in time. The thousands of trials currently recruiting or underway are themselves a mere fraction of the studies NCI has conducted or supported since its creation in 1937.

Used successfully in several industries, digital twins have the potential to forge a path toward advances in cancer care and research. Frederick National Laboratory is a lead organization in the strategic interagency collaboration between the National Cancer Institute and the U.S. Department of Energy and has been instrumental in the development of innovative technologies for creating a cancer patient digital twin.

The Federal Laboratory Consortium for Technology Transfer recently awarded the Frederick National Laboratory and National Cancer Institute Technology Showcase a 2021 State and Local Economic Development Award. The FLC is a nationwide network of more than 300 federal laboratories, agencies, and research centers that promotes federal technology transfer.

Researchers in the National Cancer Institute’s Center for Cancer Research (CCR) and the Frederick National Laboratory’s Basic Science Program have discovered molecules that could keep the body from working against a cancer treatment.